Mycomofirel 500mg Tablets contain the active ingredient Mycophenolate mofetil, an immunosuppressant used primarily to prevent the rejection of transplanted organs. Each tablet provides 500mg of Mycophenolate mofetil. This medication works by inhibiting the proliferation of immune cells, reducing the body's immune response and thus decreasing the likelihood of the body rejecting a transplanted organ. Mycomofirel is typically administered twice daily, with meals, and should be continued for as long as the transplanted organ remains at risk of rejection. Regular monitoring of blood counts is recommended due to potential side effects such as anemia, leukopenia, and thrombocytopenia. Patients are advised to consult their healthcare provider regarding potential drug interactions and appropriate dosage adjustments.